首页> 外文会议>Proceedings of the Second conference on Asia-Pacific bioinformatics >On the simultaneous use of clinical and microarray expression data in the cluster analysis of tissue samples
【24h】

On the simultaneous use of clinical and microarray expression data in the cluster analysis of tissue samples

机译:关于在组织样本的聚类分析中同时使用临床和微阵列表达数据

获取原文
获取原文并翻译 | 示例

摘要

This paper considers a model-based approach to the clustering of tissue samples of a very large number of genes from microarray experiments. It is a nonstandard problem in parametric cluster analysis because the dimension of the feature space (the number of genes) is typically much greater than the number of tissues. Frequently in practice, there are also clinical data available on those cases on which the tissue samples have been obtained. Here we investigate how to use the clinical data in conjunction with the microarray gene expression data to cluster the tissue samples. We propose two mixture model-based approaches in which the number of components in the mixture model corresponds to the number of clusters to be imposed on the tissue samples. One approach specifies the components of the mixture model to be the conditional distributions of the microarray data given the clinical data with the mixing proportions also conditioned on the latter data. Another takes the components of the mixture model to represent the joint distributions of the clinical and microarray data. The approaches are demonstrated on some breast cancer data, as studied recently in van't Veer et al. (2002).
机译:本文考虑了一种基于模型的方法来对来自微阵列实验的大量基因的组织样本进行聚类。这是参数聚类分析中的一个非标准问题,因为特征空间的尺寸(基因的数量)通常远大于组织的数量。在实践中,通常在获得组织样本的情况下也有临床数据可用。在这里,我们研究如何结合微阵列基因表达数据使用临床数据对组织样本进行聚类。我们提出了两种基于混合模型的方法,其中混合模型中组件的数量与要施加到组织样本上的簇的数量相对应。给定临床数据时,一种方法将混合物模型的成分指定为微阵列数据的条件分布,并且混合比例也以后者数据为条件。另一个采用混合物模型的组件来表示临床和微阵列数据的联合分布。最近在van't Veer等人中研究的一些乳腺癌数据证明了这些方法。 (2002)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号